Recombinant human Atrial Natriuretic Peptide（Shenzhen University）
重组人心钠肽（深圳大学）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human Atrial Natriuretic Peptide（Shenzhen University）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Basic Medicine, Chinese Academy Of Medical SciencesShenzhen University
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShenzhen UniversityInstitute Of Basic Medicine, Chinese Academy Of Medical SciencesShenzhen National Biochemical Engineering Technology Development Center +[4]
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A